v3.24.1.1.u2
Equity-Based Compensation - Schedule of Stock Options Rollforward (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Apr. 01, 2022
Options        
Shares outstanding, beginning period (in shares) 222,833 331,420    
Granted (in shares) 10,000 232,028    
Settled (in shares) 0 (124)    
Forfeited (in shares) (220,718) (340,491)    
Shares outstanding, ending period (in shares) 12,115 222,833 331,420  
Exercisable (in shares) 12,115      
Vested and expected to vest, shares (in shares) 12,115      
Weighted-Average Exercise Price        
Beginning period (in dollars per share) $ 4.74 $ 61.82    
Granted (in dollars per share) 1.58 4.56    
Settled (in dollars per share) 0 5.51    
Forfeited (in dollars per share) 5.40 60.18    
Ending period (in dollars per share) 4.28 $ 4.74 $ 61.82  
Exercisable (in usd per share) 4.26      
Vested and expected to vest (in usd per share) $ 4.28      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]        
Weighted-Average Remaining Contractual Term (years) 5 years 4 months 24 days 7 years 6 months 7 years  
Exercisable, weighted-average remaining contractual term 5 years 4 months 24 days      
Vested and expected to vest, weighted average remaining contractual term 5 years 4 months 24 days      
Aggregate intrinsic value $ 0 $ 0 $ 0  
Exercisable, aggregate intrinsic value 0      
Vested and expected to vest, aggregate intrinsic value $ 0      
Stock option, exercise price (in dollars per share)       $ 5.51